Therapeutic interchange involving replacement of rofecoxib or celecoxib with valdecoxib.
Veterans Affairs San Diego Healthcare System, CA 92161, USA.
Fionna
F
Tran
Daniel T
DT
Boggie
Melissa L
ML
Delattre
Monica G
MG
Schaefer
Anthony P
AP
Morreale
Brian K
BK
Plowman
D000368:Aged; D000369:Aged, 80 and over; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D000068579:Celecoxib; D002908:Chronic Disease; D017046:Cost Savings; D051546:Cyclooxygenase 2; D017723:Drug Utilization Review; D023381:Endpoint Determination; D005260:Female; D006787:Hospitals, Veterans; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D007555:Isoxazoles / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007783:Lactones / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D008565:Membrane Proteins; D010003:Osteoarthritis / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D011451:Prostaglandin-Endoperoxide Synthases; D011720:Pyrazoles; D013449:Sulfonamides / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013450:Sulfones; D013810:Therapeutic Equivalency; D000096926:Benzenesulfonamides
D000068579:Celecoxib; D051546:Cyclooxygenase 2; D007527:Isoenzymes; D007555:Isoxazoles; D007783:Lactones; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; C406224:valdecoxib; D000096926:Benzenesulfonamides; C496540:PTGS2 protein, human